David L. Arendsen

452 total citations
19 papers, 310 citations indexed

About

David L. Arendsen is a scholar working on Molecular Biology, Organic Chemistry and Spectroscopy. According to data from OpenAlex, David L. Arendsen has authored 19 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Spectroscopy. Recurrent topics in David L. Arendsen's work include Chemical Synthesis and Analysis (5 papers), Analytical Chemistry and Chromatography (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). David L. Arendsen is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Analytical Chemistry and Chromatography (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). David L. Arendsen collaborates with scholars based in United States and United Kingdom. David L. Arendsen's co-authors include John F. DeBernardis, Daniel J. Kerkman, Robert J. Lefkowitz, Jarl E. S. Wikberg, Kenneth E.J. Dickinson, Martin Winn, Marc G. Caron, L.M. Fredrik Leeb-Lundberg, Sarah L. Heald and P.‐O. Hagen and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

David L. Arendsen

19 papers receiving 287 citations

Peers

David L. Arendsen
Helmut Wittneben Germany
Louis Berlinguet Canada
Günter Thomas Germany
Vittorio Vecchietti Italy
Linus S. Lin United States
Hugo Gorissen Belgium
Pascal Rigollier Switzerland
Fuk‐Wah Sum United States
Herman J. Crowley United States
Hyun Ok United States
Helmut Wittneben Germany
David L. Arendsen
Citations per year, relative to David L. Arendsen David L. Arendsen (= 1×) peers Helmut Wittneben

Countries citing papers authored by David L. Arendsen

Since Specialization
Citations

This map shows the geographic impact of David L. Arendsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Arendsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Arendsen more than expected).

Fields of papers citing papers by David L. Arendsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Arendsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Arendsen. The network helps show where David L. Arendsen may publish in the future.

Co-authorship network of co-authors of David L. Arendsen

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Arendsen. A scholar is included among the top collaborators of David L. Arendsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Arendsen. David L. Arendsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Link, J. T., Bryan K. Sorensen, David L. Arendsen, et al.. (2004). Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulators. Bioorganic & Medicinal Chemistry Letters. 14(16). 4169–4172. 8 indexed citations
2.
Zhu, Gui‐Dong, David L. Arendsen, Indrani W. Gunawardana, et al.. (2001). Selective Inhibition of ICAM-1 and E-Selectin Expression in Human Endothelial Cells. 2. Aryl Modifications of 4-(Aryloxy)thieno[2,3-c]pyridines with Fine-Tuning at C-2 Carbamides. Journal of Medicinal Chemistry. 44(21). 3469–3487. 46 indexed citations
3.
Tahir, Sajid Khan, Wen‐Zhen Gu, Juan H. Leal, et al.. (2000). Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue. European Journal of Cancer. 36(9). 1161–1170. 10 indexed citations
4.
Meyer, Michael D., Arthur A. Hancock, Karin Tietje, et al.. (1997). Structure−Activity Studies for a Novel Series ofN-(Arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamines Possessing Dual 5-HT Uptake Inhibiting and α2-Antagonistic Activities. Journal of Medicinal Chemistry. 40(7). 1049–1062. 29 indexed citations
5.
DeBernardis, John F., et al.. (1987). Conformationally defined adrenergic agents. 4. 1-(Aminomethyl)phthalans: synthesis and pharmacological consequences of the phthalan ring oxygen atom. Journal of Medicinal Chemistry. 30(1). 178–184. 34 indexed citations
6.
7.
8.
DeBernardis, John F., Fatima Z. Basha, David L. Arendsen, et al.. (1986). Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at .alpha.1 and .alpha.2 adrenergic receptors. Journal of Medicinal Chemistry. 29(4). 463–467. 7 indexed citations
9.
DeBernardis, John F., Daniel J. Kerkman, Martin Winn, et al.. (1985). Conformationally defined adrenergic agents. 1. Design and synthesis of novel .alpha.2-selective adrenergic agents: electrostatic repulsion based conformational prototypes. Journal of Medicinal Chemistry. 28(10). 1398–1404. 31 indexed citations
10.
Leeb-Lundberg, L.M. Fredrik, Kenneth E.J. Dickinson, Sarah L. Heald, et al.. (1984). Photoaffinity labeling of mammalian alpha 1-adrenergic receptors. Identification of the ligand binding subunit with a high affinity radioiodinated probe.. Journal of Biological Chemistry. 259(4). 2579–2587. 71 indexed citations
11.
Leeb-Lundberg, L.M. Fredrik, Kenneth E.J. Dickinson, Sarah L. Heald, et al.. (1983). Covalent labeling of the cerebral cortex α1-adrenergic receptor with a new high affinity radioiodinated photoaffinity probe. Biochemical and Biophysical Research Communications. 115(3). 946–951. 12 indexed citations
12.
Zaugg, Harold E., David L. Arendsen, & Richard S. Egan. (1979). The contrasting behavior of cyclic and acyclic 2‐amidomethyleneresorcinols towards cyclization with acetaldehyde. Journal of Heterocyclic Chemistry. 16(1). 21–23. 1 indexed citations
13.
Winn, Martin, et al.. (1976). Drugs derived from cannabinoids. 5. .DELTA.6a,10a,-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. Journal of Medicinal Chemistry. 19(4). 461–471. 19 indexed citations
14.
Winn, Martin, David L. Arendsen, Anthony T. Dren, et al.. (1976). ChemInform Abstract: DRUGS DERIVED FROM CANNABINOIDS. 5. Δ6A,10A,‐TETRAHYDROCANNABINOL AND HETEROCYCLIC ANALOGS CONTAINING AROMATIC SIDE CHAINS. Chemischer Informationsdienst. 7(31). 1 indexed citations
15.
Plotnikoff, Nicholas P., et al.. (1975). New benzopyrans: Anticonvulsant activities. Life Sciences. 17(1). 97–103. 4 indexed citations
16.
Zaugg, Harold E. & David L. Arendsen. (1974). Synthesis of fused hydantoins by intramolecular amidoalkylation. Journal of Heterocyclic Chemistry. 11(5). 803–806. 8 indexed citations
17.
Zaugg, Harold E., et al.. (1974). Substituted chromans and tetrahydrofuro[2,3‐b]benzofurans (trapped tetrahedral intermediates) from 3‐phenyl‐2‐benzofuranones. Journal of Heterocyclic Chemistry. 11(5). 797–802. 4 indexed citations
18.
Zaugg, Harold E., Jack E. Leonard, & David L. Arendsen. (1974). Amidoalkylation of a phenol by a hydantoin. Construction of a new hetero‐tricyclic system. Journal of Heterocyclic Chemistry. 11(5). 833–834. 1 indexed citations
19.
Arendsen, David L., et al.. (1970). Base-catalyzed condensations of o-phthalaldehyde with primary amides. Synthesis and characterization of some isoindoline and phthalan derivatives. The Journal of Organic Chemistry. 35(11). 3940–3943. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helmut Wittneben Breakdown of academic impact, for papers by Louis Berlinguet Breakdown of academic impact, for papers by Günter Thomas Breakdown of academic impact, for papers by Vittorio Vecchietti Breakdown of academic impact, for papers by Linus S. Lin Breakdown of academic impact, for papers by Hugo Gorissen Breakdown of academic impact, for papers by Pascal Rigollier Breakdown of academic impact, for papers by Fuk‐Wah Sum Breakdown of academic impact, for papers by Herman J. Crowley Breakdown of academic impact, for papers by Hyun Ok
Rankless by CCL
2026